Synonyms: Miraclid® | Ulinase® | Urinastatin®
ulinastatin is an approved drug (Japan, China)
Compound class:
Endogenous peptide in human, mouse or rat
Comment: Ulinastatin is considered to be a metabolite of inter-α-trypsin inhibitor (ITI) that is one of the cleavage products from the AMBP precursor protein [3]. Compared to full length ITI, ulinastatin lacks the carboxyterminal RFSN amino acids. Functionally ulinastatin is a protease inhibitor, that plays an important role in physiological and pathological processes, and has notable anti-inflammatory activity [1-2,6]. It can be purified from healthy human urine or produced using recombinant technology.
Species: Human
|
Classification ![]() |
|
Compound class | Endogenous peptide in human, mouse or rat |
Approved drug? | Yes. Japan (0) | China (0) |
International Nonproprietary Names ![]() |
|
INN number | INN |
5938 | ulinastatin |
Synonyms ![]() |
Miraclid® | Ulinase® | Urinastatin® |
Gene/Precursor ![]() |
||||||||||
|
Database Links ![]() |
|
Ensembl Gene | ENSG00000106927 (Hs) |
GtoPdb PubChem SID | 387271625 |
Human Protein Atlas | ENSG00000106927 (Hs) |
OMIM | 176870 (Hs) |
Search PubMed clinical trials | ulinastatin |
Search PubMed titles | ulinastatin |
Search PubMed titles/abstracts | ulinastatin |
UniProtKB | P02760 (Hs) |